M6A modification in cardiovascular disease: With a focus on programmed cell death.
Genes Dis
; 11(5): 101039, 2024 Sep.
Article
in En
| MEDLINE
| ID: mdl-38988324
ABSTRACT
N6-methyladenosine (m6A) methylation is one of the most predominant internal RNA modifications in eukaryotes and has become a hot spot in the field of epigenetics in recent years. Cardiovascular diseases (CVDs) are a leading cause of death globally. Emerging evidence demonstrates that RNA modifications, such as the m6A modification, are associated with the development and progression of many diseases, including CVDs. An increasing body of studies has indicated that programmed cell death (PCD) plays a vital role in CVDs. However, the molecular mechanisms underlying m6A modification and PCD in CVDs remain poorly understood. Herein, elaborating on the highly complex connections between the m6A mechanisms and different PCD signaling pathways and clarifying the exact molecular mechanism of m6A modification mediating PCD have significant meaning in developing new strategies for the prevention and therapy of CVDs. There is great potential for clinical application.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Genes Dis
Year:
2024
Document type:
Article